SEC Form 4 · accession 0001209191-16-087742
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David F Hale
Director
Period of report
Dec 31, 2015
Accepted (ET)
Jan 4, 2016 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.38 | Dec 31, 2015 | A | 12,500 | A | — | Dec 30, 2025 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The shares subject to the option shall be 100% vested and exercisable on June 16, 2016.